< Back to search
Filter
1

CAR-T Cell Therapy, Mosunetuzumab and Polatuzumab for Treatment of Refractory/Relapsed Aggressive Non-Hodgkin's Lymphoma (NHL).

for
Refractory Non-Hodgkin Lymphoma, Relapsed Non Hodgkin Lymphoma,
Location: Miami FL
Sponsor: Lazaros Lekakis

Sex: All

Age: 18 - 70+

Code: NCT05260957

Phase2, Recruiting

Study for Subjects With Relapsed/Refractory Non- Hodgkin Lymphoma

for
Non Hodgkin's Lymphoma Refractory/Relapsed
Location: Tyler TX, Newport Beach CA
Sponsor: ImmunityBio, Inc.

Sex: All

Age: 18+

Code: NCT05618925

Phase1, Recruiting

Registry of Older Patients With Cancer

for
Chronic Myeloproliferative Disorders,
Location: Morehead City NC, New Bern NC, Greenville NC,
Sponsor: UNC Lineberger Comprehensive Cancer Center

Sex: All

Age: 65+

Code: NCT01137825

Recruiting

Patient-Reported Outcomes and Quality of Life in Adult and Pediatric Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)

for
Nodular Lymphocyte-Predominant Hodgkin Lymphoma
Location: Boston MA, New York NY, Hackensack NJ, Rochester NY,
Sponsor: St. Jude Children's Research Hospital

Sex: All

Age: 8+

Code: NCT06098430

Recruiting

ctDNA-guided Therapy Optimization in Newly Diagnosed DLBCL

for
Lymphoma, Lymphoma, B-Cell, Diffuse Large B Cell Lymphoma,
Location: New York NY
Sponsor: Hua-Jay J Cherng, MD

Sex: All

Age: 18+

Code: NCT06693830

Recruiting

Interested in new lymphoma trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Venetoclax-Obinutuzumab +/- Acalabrutinib in R/R CLL

for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Boston MA
Sponsor: Massachusetts General Hospital

Sex: All

Age: 18+

Code: NCT04560322

Phase2, Recruiting

Clonal Hematopoiesis is a Risk Factor for Chemotherapy-Related Complications

for
Lymphoma, Chemotherapeutic Toxicity
Location: Toronto
Sponsor: Sunnybrook Health Sciences Centre

Sex: All

Age: 60+

Code: NCT04053439

Recruiting

Zanubrutinib and Venetoclax in CLL (ZANU-VEN)

for
Chronic Lymphocytic Leukemia (CLL),
Location: Scarborough ME, South Weymouth MA, Boston MA
Sponsor: Dana-Farber Cancer Institute

Sex: All

Age: 18+

Code: NCT05168930

Phase2, Recruiting

A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies

for
Chronic Lymphocytic Leukemia (CLL),
Location: New Haven CT, Philadelphia PA, Bethesda MD, Durham NC,
Sponsor: Nurix Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT05131022

Phase1, Recruiting

Inotuzumab Ozogamicin and Combination Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia

for
B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT01371630

Phase1, Phase2, Recruiting

BAFFR-targeting CAR T Cells for Patients With Relapsed or Refractory B-NHL

for
Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma
Location: Charlotte NC, Minneapolis MN, Kansas City KS,
Sponsor: PeproMene Bio, Inc.

Sex: All

Age: 18+

Code: NCT05370430

Phase1, Recruiting

Evaluation of Hypertension Management and Cardiovascular Adverse Event Prevention in Patients With B-cell Malignancies Undergoing Treatment With Bruton Tyrosine Kinase Inhibitors, the HALT Study

for
Chronic Lymphocytic Leukemia,
Location: Rochester MN
Sponsor: Mayo Clinic

Sex: All

Age: 0+

Code: NCT06151730

Recruiting

A Trial to Study if REGN5837 in Combination With Odronextamab is Safe for Adult Participants With Aggressive B-cell Non-Hodgkin Lymphomas

for
B-cell Non-Hodgkins Lymphoma (B-NHL)
Location: Boston MA, New York NY, New Brunswick NJ, Louisville KY,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT05685173

Phase1, Recruiting

Quality of Life in Cutaneous Lymphoma Patients Using the Skindex29

for
Cutaneous Lymphoma
Location: Duarte CA
Sponsor: City of Hope Medical Center

Sex: All

Age: 18+

Code: NCT04670874

Recruiting

ID Of Prognostic Factors In Mycosis Fungoides/Sezary Syndrome

for
Mycosis Fungoides, Non-Hodgkin's Lymphoma
Location: Hackensack NJ, Pittsburgh PA, Iowa City IA, Dallas TX,
Sponsor: Stanford University

Sex: All

Age: 0+

Code: NCT02848274

Recruiting

Tenofovir to Prevent HBV Reactivation

for
Hepatitis B, Lymphoma, Non-Hodgkin
Location: Toronto
Sponsor: University Health Network, Toronto

Sex: All

Age: 18+

Code: NCT02186574

Phase3, Recruiting

Acalabrutinib, Obinutuzumab, and Glofitamab for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma

for
Mantle Cell Lymphoma
Location: Duarte CA
Sponsor: City of Hope Medical Center

Sex: All

Age: 18+

Code: NCT06054776

Phase2, Recruiting

Defining the Role of Palliative carE for Patients With Hematologic Malignancies Undergoing Adoptive CEllular Therapy

for
Hematologic Malignancy, Blood Cancer, Lymphoma, Leukemia,
Location: Boston MA
Sponsor: Massachusetts General Hospital

Sex: All

Age: 18+

Code: NCT05646576

Recruiting

At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer

for
Advanced Anal Carcinoma, Advanced Biliary Tract Carcinoma,
Location: Jacksonville FL, Grand Forks ND
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT05969860

Phase2, Recruiting

Evaluation of Human Immune Responses Vaccination in Patients With Lymphoma

for
Chronic Lymphocytic Leukemia, Diffuse Large B-Cell Lymphoma,
Location: Atlanta GA
Sponsor: Emory University

Sex: All

Age: 18+

Code: NCT03501576

Recruiting